Can a short drug course end malaria relapses for good?
NCT ID NCT04706130
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested how well the drug primaquine prevents the return of P. vivax malaria in 160 adults. Participants had uncomplicated malaria and normal G6PD levels. The goal was to see if a short treatment could stop relapses, aiming for a complete cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VIVAX MALARIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Institut Pasteur du Cambodge
Phnom Penh, Cambodia
More trials for these conditions
Other studies related to the condition(s) this trial covers.